External Collaborators
Collaborators in Clinical Trials

Dept. of Psychiatry and Psychotherapy, LMU Munich (CBD-FEP, CBD-ESPRIT)

Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen (CBD-FEP)

Dept. of Psychiatry, Psychotherapy and Psychosomatics, University Halle-Wittenberg (CBD-FEP)

Dept. of General Psychiatry, Medical Faculty Heidelberg, Heidelberg University (CBD-FEP)

Dept. of Psychiatry and Psychotherapy, TU Munich (CBD-FEP)

Dept. of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen (CBD-ESPRIT)

Dept. of Psychiatry and Psychotherapy, Charité Berlin (CBD-ESPRIT)

Dept. of Psychiatry and Psychotherapy, University of Cologne (CBD-ESPRIT)

---------------------------------------------

Scientific Collaborators

Depts. of Pharmacology and Biological Chemistry, University of California, Irvine, CA, USA

The Schizophrenia Center and Program in Molecular Psychiatry –
Johns Hopkins University, Baltimore, MD, USA

Institute of Pharmakology and Toxikology, University of Cologne

Institute of Radiochemistry and Experimental Molecular Imaging,
University of Cologne

Max-Planck-Institut for Brain Research, Frankfurt am Main

Unit of Drug Discovery and Development, Italian Institute of Technology, Genova, Italy

Stanley Laboratory of Developmental Neurovirology –
Johns Hopkins University, Baltimore, MD, USA

Cambridge Center for Neuropsychiatric Research CCNR – University of Cambridge, UK

Dept. of Pharmacology, University of Texas Health Science Center, San Antonio, TX, USA

---------------------------------------------

curantis UG (ltd.)

RG Translational Research in Psychiatry • Central Institute of Mental Health - Disclaimer